Elsevier

Vaccine

Volume 8, Issue 4, August 1990, Pages 390-396
Vaccine

Paper
Antigenic analysis of serotype O foot-and-mouth disease virus isolates from the Middle East, 1981 to 1988

https://doi.org/10.1016/0264-410X(90)90100-ZGet rights and content

Abstract

During the period 1981–1988 foot-and-mouth disease virus (FMDV) serotype O continued to be isolated from outbreaks in the Middle East. Field isolates submitted to the World Reference Laboratory have been examined in relation to reference strains by either complement fixation, virus neutralization or enzyme-linked immunosorbent assays. Most isolates were related to the European type O1 reference strains although strains emerging in late 1987 and 1988 were more closely related to O1/Manisa. In addition, FMDV isolates from Libya in 1981 and Syria in 1987 have shown very little relationship to these reference strains, although evidence of their persistence and spread has not been demonstrated.

References (18)

There are more references available in the full text version of this article.

Cited by (43)

  • Genetic variation and evolution of foot–and–mouth disease virus serotype A in relation to vaccine matching

    2021, Vaccine
    Citation Excerpt :

    The antigenic relationship of viruses based on their neutralization by antibodies is given by the following ratio: ‘r1′ = neutralizing antibody titer against the heterologous virus/neutralizing antibody titer against the homologous virus. Serological relationships between the vaccine strain and field isolates were evaluated according to the criteria previously described [30,31]. The cut-off value of 0.3 was used by OIE/FAO Foot-and-Mouth Disease Reference Laboratory Network.

  • Evolution of antigenic and genetic characteristics of foot-and-mouth disease virus serotype A circulating in Thailand, 2007–2019

    2020, Virus Research
    Citation Excerpt :

    The reference vaccine strains and field isolates (n = 133) were titrated using an indirect sandwich ELISA (Kitching et al., 1988) to determine the working dilution for the LP ELISA. The criteria for interpreting r-values are as follow (Samuel et al., 1990): r = 0–0.19: A highly significant serological difference between the isolate and the reference vaccine strain.

  • Genetic and antigenic relationship of foot–and–mouth disease virus serotype O isolates with the vaccine strain O1/BFS

    2018, Vaccine
    Citation Excerpt :

    The antigenic relationship of viruses based on their neutralization by antibodies is given by the following ratio: ‘r1’ = neutralizing antibody titer against the heterologous virus/neutralizing antibody titer against the homologous virus. Serological relationships between vaccine strain and field isolates were evaluated according to criteria previously described [24,25]. The r1 values ≥0.3 are indicative of cross protection, whereas values of <0.3 indicate dissimilar vaccine strains and test isolates.

  • Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity

    2016, Virology
    Citation Excerpt :

    Neutralizing titers were reported as the reciprocal of the last serum dilution to neutralize 100 TCID50 of homologous FMDV in 50% of the wells, as previously described (Rweyemamu et al., 1978). One-way antigenic relations (r1-values) of mutant viruses relative to A24 FMDV WT reference virus were calculated as the ratio between the heterologous and homologous serum titers and were interpreted as described by Samuel et al. (1990). In particular, r1-values between 0 and 0.19 indicate highly significant antigenic variation to the reference strain; values of 0.20–0.39 show antigenic relatedness to the reference strain; and values of 0.40–1.0 (and above) demonstrates that the reference and mutant viruses are antigenically similar.

  • Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge

    2015, Vaccine
    Citation Excerpt :

    Vaccines therefore need to be custom-made to be effective. One approach to address the problem of antigenic variation in the various epidemiological clusters [2,44] would be the development of cross-serotype and intra-serotype chimeric vaccines [25]. The proposed strategy entails the development of chimeric FMDV by substituting antigenic-coding regions such as the external capsid proteins (1B-1D/2A) in an infectious genome-length cDNA clone of a suitable strain [34].

  • Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus

    2011, Infection, Genetics and Evolution
    Citation Excerpt :

    Antigenic analysis recently reported by the WRL, Pirbright, UK shows that a virus (As/PAK/29/2009) of this Group was not efficiently neutralized by antisera generated against the Asia-1/Shamir vaccine (WRL-FMD, 2010). The r1 value has been used previously to ascertain antigenic relationships between the FMDV field isolates and the vaccine strains (Nayak et al., 2001; Parlak et al., 2007; Rweyemamu, 1984; Samuel et al., 1990). Using VNT, r1 values of ⩾0.3 have been shown to reflect a close antigenic relationship between the field isolates and vaccine strains, indicative of good protection by the vaccine, whereas values <0.3 reflect a distant antigenic relationship, indicating that the vaccine is unlikely to protect against the field isolates.

View all citing articles on Scopus

Present address: Springfield Cottage, 14 Norton Bavant, Warminster, Wiltshire, UK

View full text